W. Appel

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

A. Bezjak, J. V. van Meerbeeck, C. Faivre-Finn, 2017, The Lancet. Oncology.

Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial.

W. Ryder, R. Rintoul, C. Faivre-Finn, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

1303PDNivolumab in previously treated patients with metastatic squamous NSCLC: Results of a European single-arm, phase 2 trial (CheckMate 171) including patients aged ≥70 years and with poor performance status

J. Jassem, L. Paz-Ares, T. Ciuleanu, 2017 .

CONVERT: An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS).

A. Bezjak, C. Faivre-Finn, P. Lorigan, 2016 .

Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial.

K. Hood, S. Noble, D. Ferry, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations.

J. Milanowski, E. Felip, J. V. van Meerbeeck, 2020, European journal of cancer.

Late radiation morbidity in a patient with carcinoma of the cervix.

C. West, S. Davidson, W. Appel, 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

OA 02.03 Prophylactic Irradiation of Tracts (PIT) in Patients with Pleural Mesothelioma: Results of a Multicenter Phase III Trial

R. Rintoul, C. Faivre-Finn, M. Peake, 2017 .